← Leaderboards
Eric Wickstrom
Thomas Jefferson University
$2,403,438
Attributed
$4,757,786
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2008–19$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,757,786 · 12
By mechanism
R01$3,137,191 · 3
R44$834,494 · 1
R21$307,455 · 1
R41$299,774 · 1
S10$97,226 · 1
R03$77,396 · 1
Top collaborators
- Mathew L Thakur7 shared
- Edith P. Mitchell4 shared
- Brian David Gray3 shared
- Koon Y Pak3 shared
- Miguel Castro1 shared
- Yuan-Yuan Jin1 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Ya Wang$3,768,156
- Edith P. Mitchell$2,725,409
- Jun He$3,802,681
- Yedy Iswrael$392,157
- Ya-Ming Hou$21,661,043
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignOncogenesFutureImageSiteAnalogPositron-Emission TomographyLigandsMeasurementProteinsReceptorXenograft ProcedureTissuesBaseTumorPeptide Nucleic AcidsCellsGeneticMessenger RnaUptakeDiscipline Of Nuclear MedicineBloodMalignant Neoplasm Of PancreasCytoplasm
Grant awards (20)
microRNA-21 Blockade of Triple Negative Breast Cancer$299,774
R41 · FY2019 · CA · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$519,862
R01 · FY2013 · CA · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$563,160
R01 · FY2012 · CA · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$586,293
R01 · FY2011 · CA · contact PI
KINETIC PATHWAY OF GROWTH FACTOR BINDING TO RECEPTOR$1,036
P41 · FY2011 · RR · contact PI
THREE DIMENSIONAL PROJECTION ENVIRONMENT FOR MOLECULAR DESIGN AND SURGICAL SIMU$1,036
P41 · FY2011 · RR · contact PI
PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy$623,627
R01 · FY2010 · CA · contact PI
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer$376,588
R44 · FY2010 · CA
Neuronal mRNA PET Imaging$152,955
R21 · FY2010 · DA · contact PI
THREE DIMENSIONAL PROJECTION ENVIRONMENT FOR MOLECULAR DESIGN AND SURGICAL SIMU$1,388
P41 · FY2010 · RR · contact PI
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer$342,141
R44 · FY2009 · CA
Neuronal mRNA PET Imaging$154,500
R21 · FY2009 · DA · contact PI
THREE DIMENSIONAL PROJECTION ENVIRONMENT FOR MOLECULAR DESIGN AND SURGICAL SIMU$790
P41 · FY2009 · RR · contact PI
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer$115,765
R44 · FY2008 · CA
SITE SPECIFIC GENE INSERTION BY TRANSPOSITION$240,740
R01 · FY2001 · CA
ALKYLATING &CLEAVING ANTIC-MYC DNAS FOR BREAST CANCER$38,698
R03 · FY2001 · TW
OLIGONUCLEOTIDE INHIBITION OF CELL PROLIFERATION$369,730
R01 · FY2000 · CA
SITE SPECIFIC GENE INSERTION BY TRANSPOSITION$233,779
R01 · FY2000 · CA
JEFFERSON SHARED CIRCULAR DICHROISM FACILITY$97,226
S10 · FY2000 · RR
ALKYLATING &CLEAVING ANTIC-MYC DNAS FOR BREAST CANCER$38,698
R03 · FY2000 · TW